The worldwide biotechnology industry was worth USD 752.88 billion in 2020, and it is predicted to increase at a 15.83 percent compound annual growth rate (CAGR) from 2021 to 2028. Because of the rise of the biotechnology sector in developing nations like India and China, the market is being driven by favourable government initiatives. Government activities are aimed at streamlining the medication regulatory pathway, standardising clinical studies, enhancing reimbursement policies, and expediting the product approval process, all of which will provide the industry with lucrative growth potential. The development of therapeutic proteins and other medications has been aided by the growing use of biotech solutions. The need for medication discovery and development has grown as the prevalence of chronic diseases has increased. Due to the broad nature of the application, it is being employed more frequently in various industrial areas. The increasing use of organic products in agriculture is also contributing to market expansion.
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy : An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information Leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Decoding pediatric appendicitis disease: Glycosylation insights via HPLC and mass spectrometry
Dalma Dojcsak, University of Miskolc, Hungary
Title : Investigation and optimization of DNA isolation efficiency using Ferrite-based magnetic nanoparticles
Timea Gerzsenyi, University of Miskolc, Hungary